Less is known about the systemic effects on the gut as the first organ in contact with alcohol and on the consequences on inflammation and immune function. Chronic alcohol intake can lead to increased gut permeability, bacterial translocation and alterations in the gut microbiome in animal models. [5] [6] [7] Recently bacterial translocation has been shown in healthy volunteers after a single alcohol binge. [8] On immune cells, acute alcohol intake seems to have dichotomous effects. On the one hand alcohol induced liver injury is driven by pro-inflammatory reactions, whereas in the long-term, immunosuppressive and anti-inflammatory effects have been described. [9] These immune effects seem to be driven by endotoxin or other bacterial products via Toll-like receptors that are translocated to the circulation via a defective gut barrier. [10] 2
Hypothesis
We hypothesize that binge drinking impairs gut barrier, increases bacterial translocation and causes inflammation. This leads to an early increase in neutrophil and monocyte function but also an increase in oxidative stress. (see Figure 1 ). To clarify the role of liver damage in alcohol induced immune disorder we utilized the Lieber-DeCarli model of alcohol feeding on C57BL/6 mice that exhibit similar damage to the gut barrier and microbiome as humans do but only develop very mild alcoholic liver disease (ALD). We found a significantly increased ex vivo clearance capacity of whole blood, a trend to improved neutrophil function, as well as a significantly faster, more efficient clearance of pathogens from the blood in early stages of experimentally induced sepsis. When the livers of these mice were damaged with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) before the alcohol feeding period, the before mentioned advantages in ex vivo function tests were lost.
We therefore, hypothesize that alcohol by itself has immune activating properties as long as the liver is still functional. However, once the liver has been damaged the effectiveness of the immune system decreases with the degree of liver disease. This study should test whether one episode of binge drinking in otherwise healthy volunteers causes bacterial translocation and innate immune activation.
Recruitment
Healthy volunteers will be recruited from the volunteer database of the Clinical
Research Center, Medical University Graz 
Inclusion criteria
• Participant is willing and able to give informed consent for participation in the study.
• Age above 18 years
• Willingness to abstain from alcohol 48h prior to the study visits
Exclusion criteria
• Alcohol abuse o Alcohol Use Disorders Identification Test ≥ 8 in men or ≥ 7 in women or o CAGE test ≥ 2 (both men and women)
• Elevated liver function test
• Any disease or medication that does not allow concomitant consumption of alcohol
• Women: pregnancy and lactation
Visit Schedule
Volunteers will undergo 1 screening visit and 2 study visits.
The screening visit duration is approximately 1 hour, the first study visits will last at least 5 hours with an optional observation/recovery period thereafter until the alcohol breath test is below 0.5 ‰. On the next day patients will have to perform the gut permeability test at home and will deliver the urine sample together with a stool sample and a questionnaire to the trial centre. Table 1 Schedule of assessments
Screening visit 1
Male and female healthy volunteers who accomplish the inclusion criteria and none of the exclusion criteria are eligible for the study and will undergo the following investigation procedures in the screening visit, after signing the informed consent:
• Detailed explanation of the study procedures, including the intake of alcohol under medical supervision
• Check inclusion and exclusion criteria
• Check for demographic data, medical and surgical history and concomitant medication
• Date of birth, gender, smoking status, alcohol consumption
• Body weight and body height
• Vital signs: resting pulse and blood pressure
• Physical examination
• Pregnancy test in women of childbearing age.
• Blood sampling
• Distribution of the material for the gut permeability urine test and stool Subjects will be informed about the nature of the study, including the intake of alcohol. The patients have to sign that they will not use a car or a machine on the day of the study. They have to state how they will travel home after the study (either taxi, public transport or being picked up by an adult friend or family member).
As part of this visit the following procedures will be performed:
• Body weight
• Pregnancy test in women of childbearing age
• Alcohol breath test
• Blood sampling via a venous access line before alcohol consumption and every hour for 4 hours.
• Consumption of 2 ml vodka 40% v/v ethanol/kg body weight in a total volume of 300 ml orange or strawberry juice (alcohol group) or consumption of 2 ml tap water/kg body weight in a total volume of 300 ml orange or strawberry juice (control group), or 75g of fructose in 300ml of water, or a mixed caloric drink (Fortimel compact, 10kcal/kg)
Subjects from the alcohol group will be monitored at the Clinical Research Center until the alcohol breath test is below 0.5 ‰. Subjects will be provided with a taxi voucher.
Visit 3
24h after visit 1 they patients will have to perform the gut permeability urine test for 5h at home, collect a stool sample and fill in the self-administered hangover questionnaire and will have to bring the urine sample, the stool sample and the questionnaire to the trial site.
Methods

Sample size
In order to determine the magnitude of effect on gut permeability and innate immune function by a single alcohol binge, we intend to perform a pilot study on 46 healthy volunteers (16 in the alcohol group, 30 in the control groups).
Tests
The assays described in this section are the current state of the art. It is possible that the methodology changes until analysis or that assays need to be exchanged for technical reasons.
Gut permeability and inflammation
A ready-to-use solid-phase sandwich ELISA (Immundiagnostik AG, Bensheim, Germany) is used to detect DAO, Zonulin and Calprotectin in serum and stool samples.
The test is performed according to the manufacturer's instructions.
Lactulose/Mannitol test: After overnight fasting, the patient drinks a solution of 100 ml water containing 10g lactulose, 1g D-mannitol and 20g sucrose. Urine is collected over 5 hours while fasting is continued for 3 hours after study start. The urine volume collected during the 5 hours is wrote down and 1ml aliquots are frozen immediately at -80°C with 10% of a 1% thimerosal solution for subsequent analysis by NMR spectroscopy. is used to detect LBP and sCD14 levels in EDTA plasma samples.
Bacterial products
Endotoxin
Neutrophil function
The Phagoburst® kit (Glycotope, Heidelberg, Germany) will be used to determine activation and burst profiles of neutrophils and monocytes by flow cytometric analysis. Cells will be discriminated forward-side-scatter characteristics. Phagocytosis will be assessed by Phagotest® (Glycotope, Heidelberg, Germany), a flow cytometric analysis using FITC-labelled E. coli bacteria.
Statistical analysis
Data will be analyzed with SPSS 21. Data will be described using median and quartiles or percentage of the total group as appropriate. All data will be checked for normal distribution. Differences in dependent categorical variables (questionnaire data) will be assessed by McNemar test. Differences in continuous variables over time (all other variables) will be assessed by ANOVA or Friedman tests, depending on the distribution of the data. Bonferroni correction for multiple testing will be used. Pearson or Spearman correlation, depending on the distribution of data, will be used to assess correlation between variables (blood alcohol, gut permeability, bacterial translocation, neutrophil function, oxidative stress). All tests will be performed on a 5% significance level. The study participants are healthy volunteers. They will get a compensation of 100 € for completing all study visits to cover their expenses due to the participation in this study. Binge drinking can potentially be harmful, therefore the dose of alcohol chosen is at the lowest limit to fulfil the definition of binge drinking. Furthermore, several safety measures will be applied: Patients will be monitored until they recover; they are not allowed to drive a car on the day of the study and will therefore receive taxi vouchers or need to use public transport and/or need to be accompanied by an adult friend or family member on their way home.
Participants with not benefit directly for the participation in this study. Participants will benefit indirectly from a detailed assessment of their health status. As a further benefit the Principal Investigator of the study will inform each participant individually on the medical risks of binge drinking at visit 2. Taken together in our view the risks and benefits of the study are balanced.
The protocol, informed consent form and the participant information sheet have been submitted to the Ethics Committee of the Medical University of Graz, Austria.
The Investigator will obtain approval from the Ethics Committee of the Medical University of Graz, Austria for all amendments to the original approved documents.
Quality control
The study will be performed in accordance to the ICH-GCP guidelines.
